Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands

PLoS Pathogens

Volumn 6, Issue 10, 2010, Pages

  Dölken, Lars ^a   Krmpotic, Astrid ^b   Kothe, Sheila ^a   Tuddenham, Lee ^c   Tanguy, Mélanie ^c   Marcinowski, Lisa ^a   Ruzsics, Zsolt ^a   Elefant, Naama ^d   Altuvia, Yael ^d   Margalit, Hanah ^d   Koszinowski, Ulrich H ^a   Jonjic, Stipan ^b   Pfeffer, Sébastien ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; VIRUS RNA; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PHENOTYPE; RNA STABILITY; SALIVARY GLAND; VIRAL GENETICS; VIRUS LOAD; VIRUS TRANSMISSION; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; C57BL MOUSE; CYTOMEGALOVIRUS; GENE INACTIVATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; TRANSGENIC ORGANISM; VIROLOGY;

CYTOMEGALOVIRUS; HERPESVIRIDAE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENE KNOCKOUT TECHNIQUES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICRORNAS; MODELS, BIOLOGICAL; ORGANISMS, GENETICALLY MODIFIED; RNA, VIRAL; SALIVARY GLANDS; VACCINES, ATTENUATED; VIRAL LOAD;

EID: 78449255206     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001150     Document Type: Article

References (35)

1. Mocarski ES, Shenk T, Pass RF (2007) Cytomegaloviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, et al., eds. Fields Virology. 5th ed. Philadelphia: Lippincott, Williams & Wilkins. pp 2701-2772.
2. Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA (2007) The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol 85: 46-54.
3. Gottwein E, Cullen BR (2008) Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3: 375-387.
4. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
5. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
6. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
7. Sullivan CS, Sung CK, Pack CD, Grundhoff A, Lukacher AE, et al. (2009) Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection. Virology 387: 157-167.
8. Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, et al. (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188: 1047-1054.
9. Polic B, Jonjic S, Pavic I, Crnkovic I, Zorica I, et al. (1996) Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J Gen Virol 77(Pt 2): 217-225.
10. Buck AH, Santoyo-Lopez J, Robertson KA, Kumar DS, Reczko M, et al. (2007) Discrete clusters of virus-encoded microRNAs are associated with complementary strands of the genome and the 7.2-kilobase stable intron in murine cytomegalovirus. J Virol 81: 13761-13770.
11. Dolken L, Perot J, Cognat V, Alioua A, John M, et al. (2007) Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. J Virol 81: 13771-13782.
12. Dunn W, Trang P, Zhong Q, Yang E, van Belle C, et al. (2005) Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell Microbiol 7: 1684-1695.
13. Grey F, Antoniewicz A, Allen E, Saugstad J, McShea A, et al. (2005) Identification and characterization of human cytomegalovirus-encoded micro- RNAs. J Virol 79: 12095-12099.
14. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33: e36.
15. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
16. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, et al. (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99: 8826-8831.
17. Sacher T, Podlech J, Mohr CA, Jordan S, Ruzsics Z, et al. (2008) The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe 3: 263-272.
18. Campbell AE, Cavanaugh VJ, Slater JS (2008) The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol 197: 205-213.
19. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, et al. (1993) Immune response in mice that lack the interferon-gamma receptor. Science 259: 1742-1745.
20. Lussier G, Berthiaume L, Payment P (1974) Electron microscopy of murine cytomegalovirus: development of the virus in vivo and in vitro. Arch Gesamte Virusforsch 46: 269-280.
21. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH (1989) Siterestricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med 169: 1199-1212.
22. Osborn JE, Walker DL (1971) Virulence and Attenuation of Murine Cytomegalovirus. Infect Immun 3: 228-236.
23. Reddehase MJ, Weiland F, Munch K, Jonjic S, Luske A, et al. (1985) Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 55: 264-273.
24. Smith MG (1954) Propagation of salivary gland virus of the mouse in tissue cultures. Proc Soc Exp Biol Med 86: 435-440.
25. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, et al. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
26. Matloubian M, David A, Engel S, Ryan JE, Cyster JG (2000) A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 1: 298-304.
27. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, et al. (2005) Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 3: e113.
28. Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, et al. (2004) The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172: 6362-6372.
29. Day C, Patel R, Guillen C, Wardlaw AJ (2009) The chemokine CXCL16 is highly and constitutively expressed by human bronchial epithelial cells. Exp Lung Res 35: 272-283.
30. Grey F, Meyers H, White EA, Spector DH, Nelson J (2007) A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog 3: e163.
31. Stern-Ginossar N, Saleh N, Goldberg MD, Prichard M, Wolf DG, et al. (2009) Analysis of human cytomegalovirus-encoded microRNA activity during infection. J Virol 83: 10684-10693.
32. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
33. Brune W, Hengel H, Koszinowski UH (2001) A mouse model for cytomegalovirus infection. Curr Protoc Immunol Chapter 19: Unit 19 17.
34. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H (1984) Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312: 548-551.
35. Koo GC, Peppard JR (1984) Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma 3: 301-303.